Senna M. Lammers
Maastricht, LI, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Response to letter: a critical appraisal of the DATA trial analysis on the prognostic and predictive value of the luminal-like subtype.
Journal: ESMO open
Published: April 16, 2025
Response to letter re: The prognostic and predictive value of the luminal-like subtype in hormone receptor-positive breast cancer: an analysis of the DATA trial.
Journal: ESMO open
Published: February 26, 2025
The prognostic and predictive value of the luminal-like subtype in hormone receptor-positive breast cancer: an analysis of the DATA trial.
Journal: ESMO open
Published: October 12, 2024
Ovarian function recovery in breast cancer patients receiving adjuvant anastrozole treatment: updated results from the phase 3 DATA trial.
Journal: Breast cancer research and treatment
Published: May 05, 2024
Treatment and survival of patients diagnosed with high-risk HR+/HER2- breast cancer in the Netherlands: a population-based retrospective cohort study.
Journal: ESMO open
Published: December 01, 2023
The prognostic impact of BMI in patients with HR+/HER2- advanced breast cancer: a study of the SONABRE registry.
Journal: Breast cancer research and treatment
Published: July 11, 2023
The prognostic and predictive effect of body mass index in hormone receptor-positive breast cancer.
Journal: JNCI cancer spectrum
Published: July 05, 2023
Extended adjuvant aromatase inhibition after sequential endocrine therapy in postmenopausal women with breast cancer: follow-up analysis of the randomised phase 3 DATA trial.
Journal: EClinicalMedicine
Published: December 20, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026